Dr. Erin Andrea Gross, MD

Dr. Gross practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Gross' NPI, 1013175009, was assigned on May 27, 2008. Dr. Gross graduated from Albany Medical College in 2005. Dr. Gross holds California license A99544.

Dr. Gross' primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Gross' primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Gross is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Gross to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gross practices, 3 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Gross' primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Gross is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dr. Gross is licensed in California.

Dmand AI lists menopause, pelvic prolapse and vaginal infection among the conditions Dr. Gross treats.

CMS data shows 163 Medicare services from Dr. Gross across 4 procedure codes in 2024, for 134 Medicare patients. Medicare paid $13,471 for them. Every service was in an office.

CMS counts 134 Medicare patients who saw Dr. Gross in 2024. The largest group is 65 to 74, with 72 patients. 61% of them have high cholesterol, and 54% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gross' median patient age at 37, with 99% women.

In 2024, Dr. Gross wrote 331 Medicare Part D claims for 112 patients. 89% of them were for generic drugs. CMS names the drug for 223 of them, across 6 drugs with 11 or more claims each, at $30,588 in total drug cost. In 2023, CMS named 195 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gross for performance year 2024, reported as part of a group. Dr. Gross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gross as offering telehealth.

Dmand AI links 2 papers to Dr. Gross in 2024. The most frequent topics are Physicians. Dr. Gross' most frequent co-authors are Sally Liu Baxter, MD, Teresa Lynn Helsten, MD and Christopher A. Longhurst, MD.

Dmand AI links Dr. Gross to 1 clinical trial. Conditions studied include Leiomyoma and Neoplasms, Muscle Tissue.

CMS Open Payments shows 3 general payments to Dr. Gross from 1 drug or device company from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Heron Therapeutics, Inc. paid the most, $121. It also lists 1 research payment totaling $4,675 in 2016.

Dmand AI lists 2 awards for Dr. Gross, most recently CMS Stage 1 EHR in 2013.

Dr. Gross graduated from Albany Medical College in 2005. Dr. Gross is a member of American College of Obstetricians and Gynecologists.

Dr. Gross is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.